Journal article Open Access

Protocol effectiveness of COVID-19 vaccines on variant of concern. A systematic review of observational studies

Isabelle Boutron; Anna Chaimani


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.5511936">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.5511936</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.5511936"/>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0002-5263-6241">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0002-5263-6241</dct:identifier>
        <foaf:name>Isabelle Boutron</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Université de Paris, Inserm, Cochrane France, AP-HP, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0003-2828-6832">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0003-2828-6832</dct:identifier>
        <foaf:name>Anna Chaimani</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Université de Paris, Inserm, Cochrane France, AP-HP, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Protocol effectiveness of COVID-19 vaccines on variant of concern. A systematic review of observational studies</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2021</dct:issued>
    <dcat:keyword>COVID-19 vaccines, COVID-19; Coronavirus; SARS-CoV2; Vaccine against SARS-CoV2;COVID-19 Vaccination;</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2021-09-16</dct:issued>
    <dct:language rdf:resource="http://publications.europa.eu/resource/authority/language/ENG"/>
    <owl:sameAs rdf:resource="https://zenodo.org/record/5511936"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/5511936</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.5511935"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/covid-19"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/covid-nma"/>
    <owl:versionInfo>V2 31-8-2021</owl:versionInfo>
    <dct:description>&lt;p&gt;This is a protocol of a living systematic review of vaccine observational studies. Our aim is&amp;nbsp;to assess the effectiveness of COVID-19 vaccines against SARS CoV-2 variants of concern Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) in addition to any other newly discovered variants of concerns as identified by WHO over time.. All results will be made available on the COVID-NMA platform (https://covid-nma.com/) and updated weekly.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.5511936"/>
        <dcat:byteSize>2051859</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/5511936/files/covid_nma_os_vaccines_protocol_2021-09-01 (1).pdf"/>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
562
236
views
downloads
All versions This version
Views 562562
Downloads 236236
Data volume 484.2 MB484.2 MB
Unique views 530530
Unique downloads 213213

Share

Cite as